Wealthfront Advisers LLC Increases Stake in Healthpeak Properties, Inc. (NYSE:DOC)

Wealthfront Advisers LLC grew its position in shares of Healthpeak Properties, Inc. (NYSE:DOC) by 169.7% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 691,502 shares of the real estate investment trust’s stock after acquiring an additional 435,066 shares during the quarter. Wealthfront Advisers LLC’s holdings in Healthpeak Properties were worth $14,563,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the stock. Avior Wealth Management LLC bought a new stake in shares of Healthpeak Properties during the third quarter worth $37,000. Groupama Asset Managment acquired a new stake in Healthpeak Properties in the third quarter worth about $37,000. Wiser Advisor Group LLC acquired a new stake in shares of Healthpeak Properties during the third quarter worth about $42,000. Continuum Advisory LLC acquired a new position in Healthpeak Properties in the third quarter valued at approximately $44,000. Finally, AdvisorNet Financial Inc lifted its holdings in Healthpeak Properties by 34.5% in the fourth quarter. AdvisorNet Financial Inc now owns 2,193 shares of the real estate investment trust’s stock valued at $44,000 after acquiring an additional 563 shares during the period. 93.57% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages recently commented on DOC. Mizuho dropped their price target on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Thursday, December 5th. Morgan Stanley upgraded Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target on the stock in a report on Wednesday, January 15th. Wedbush dropped their price target on Healthpeak Properties from $27.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, February 14th. Robert W. Baird decreased their price objective on Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating for the company in a research report on Tuesday, February 11th. Finally, Scotiabank reduced their price objective on Healthpeak Properties from $24.00 to $23.00 and set a “sector outperform” rating for the company in a report on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $23.92.

Healthpeak Properties Stock Down 1.8 %

NYSE DOC opened at $20.31 on Wednesday. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.96. The stock’s 50 day moving average is $20.21 and its two-hundred day moving average is $21.27. The company has a market capitalization of $14.20 billion, a price-to-earnings ratio of 58.02, a PEG ratio of 2.17 and a beta of 1.14. Healthpeak Properties, Inc. has a 1-year low of $16.66 and a 1-year high of $23.26.

Healthpeak Properties Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 26th. Shareholders of record on Friday, February 14th were given a dividend of $0.305 per share. This is a boost from Healthpeak Properties’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Friday, February 14th. This represents a $1.22 annualized dividend and a dividend yield of 6.01%. Healthpeak Properties’s payout ratio is presently 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.